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E-mail address: s-sligar@uiuc.edu (S.G. Sligar).Nanodiscs are soluble nanoscale phospholipid bilayers which can self-assemble integral membrane
proteins for biophysical, enzymatic or structural investigations. This means for rendering mem-
brane proteins soluble at the single molecule level offers advantages over liposomes or detergent
micelles in terms of size, stability, ability to add genetically modiﬁable features to the Nanodisc
structure and ready access to both sides of the phospholipid bilayer domain. Thus the Nanodisc sys-
tem provides a novel platform for understanding membrane protein function. We provide an over-
view of the Nanodisc approach and document through several examples many of the applications to
the study of the structure and function of integral membrane proteins.
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Membrane proteins have been difﬁcult to study from the mech-
anistic perspective as many of the biophysical and chemical tech-
niques applicable to soluble enzymes fail to deal with insoluble
aggregates. Ideally, one would prefer to have a membrane protein
of interest in a solubilized state for ease in puriﬁcation, functional
biochemical assay, application of various biophysical methods and
spectroscopies, crystallization for structure determination and bio-
chemical manipulations that maintain the target protein in a stable
state. Historically, membrane protein solubilization utilized deter-
gents to form mixed detergent–protein–lipid micelles. However,
detergent poses a hazard to membrane protein stability and the
excess micellar phase can interfere with many assay techniques
and often has non-ideal optical properties (absorbance and light
scattering) as well as undesired partitioning of substrates and
products into the excess detergent micelle. Detergent also presents
technical obstacles during the manipulation of membrane proteins
as they often co-concentrate with the protein target and can lead
to inactive or denatured entities. Furthermore, many membranechemical Societies. Published by E
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IL 61801, United States. Fax:protein systems require speciﬁc types of phospholipids to maintain
active function, a requirement which is not mimicked by detergent
micelles. Liposome preparations have been used to incorporate
membrane proteins and this approach has been found to be useful
when compartmentalization of each side of the bilayer is needed,
as for example in the assay of ion channels. However liposomes
are large, unstable and difﬁcult to prepare with precisely con-
trolled size and stoichiometry.
Nanodisc technology offers a solution to some of these chal-
lenges. In this approach, the membrane protein target is transiently
solubilizedwith a detergent in the presence of phospholipids and an
encircling amphipathic helical protein belt, termed a membrane
scaffold protein (MSP) [1]. When the detergent is removed, by dial-
ysis or adsorbtion to hydrophobic beads, the target membrane pro-
tein simultaneously assembles with phospholipids into a discoidal
bilayer with the size controlled by the length of the MSP. The resul-
tant Nanodiscs thus keep membrane proteins in solution, provide a
native-like phospholipidbilayer environment thatprovides stability
and functional requirements of the incorporated target and also al-
low control of the oligomeric state of the target membrane protein.
Nanodiscs thus provide a cassette, rendering membrane proteins
soluble at the singlemolecule level, andopeningup structural–func-
tional investigations that were heretofore limited to the class of sol-
uble proteins and enzymes. Membrane proteins having many
different topologies have been introduced into Nanodiscs (Table
1). In addition, the provision of a solublemembrane surfacewith de-
ﬁnedphospholipid compositionhas provided ameans to investigate
themechanismofmolecular recognitionbetweenprotein andmem-
branes. In the ensuing sections we highlight the utility of the Nano-
disc platform through several speciﬁc examples and suggest future
applications.lsevier B.V. All rights reserved.
Table 1
Proteins, detergents and phospholipids used for Nanodisc formation.
Target protein class Phospholipids Detergents
Single TM, seven TM, multi-TM,
cytochrome P450s, multi-protein
complex, peripheral, tethered
DPPC, DMPC, POPC, phosphatidylcholine (PC)/PS,
PC/PE, E. coli lipids, Sf9 membrane, PC/PG,
PC/DOTAP, soy PC, egg PC, soy asolectin
CHAPS, cholate, cymal, deoxycholate, digitonin, dihexanoyl PC,
dodecylmaltoside (DDM), Emulgen 911, FOS-choline,
octylglucoside (OG), sodium dodecylsulfate,
Triton X-100, Tween 20
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The Nanodisc is a non-covalent assembly of phospholipid and a
genetically engineered ‘‘membrane scaffold protein” (MSP) which
itself is based upon the sequence of human serum apolipoprotein
AI. The phospholipid associates as a bilayer domain while two mol-
ecules of MSP wrap around the edges of the discoidal structure in a
belt-like conﬁguration, one MSP covering the hydrophobic alkyl
chains of each leaﬂet (Fig. 1). A detailed picture of the Nanodisc
self-assembly process has emerged from a combination of theoret-
ical simulations using coarse grain and whole-atom molecular
dynamics and solution X-ray scattering [2,3]. A critical component,
the MSP, is related to the serum apolipoproteins that are the pri-
mary component of high density lipoproteins (rHDL). The latest
MSP sequences were engineered into a synthetic gene optimized
for expression in Escherichia coli and include various afﬁnity tags
(6xHis, FLAG, Cys, etc.) and of varying lengths which control theFig. 1. Illustrations of Nanodisc structures. Top panel: Nanodiscs composed of MSP1D1 a
and blue. Bottom panel: Nanodisc composed of MSP1E3D1, phospholipid and bR trimer (2
same scale for comparison.overall Nanodisc size (see Table 2). Although a relatively new tech-
nology, we have spent considerable effort over the past few years
to characterize Nanodiscs and their assemblies with integral mem-
brane protein targets. For instance, the phospholipid bilayer and
structural organization of the Nanodisc has been probed by atomic
force microscopy and analyzed using small angle X-ray scattering
(SAXS), conﬁrming that the Nanodisc contains a phospholipid bi-
layer with MSP associated at the edge [1,4,5]. The belt organization
was directly proven by solid state magic angle spinning NMR of a
uniformly labeled 13C,15N-labeled MSP [6].
Some simple rules and relationships arise from the belt-disk
organization, providing a check for self-consistency. The diameter
of the Nanodisc is dictated by the length of the MSP belt at the
optimum lipid content. This relationship is supported by experi-
mental SAXS and size exclusion chromatography (SEC) on data ob-
tained using MSPs of different lengths [4,5]. MSP and
apolipoprotein AI consist of 22-mer helical repeats punctuated bynd phospholipid shown in side view and top view. The two MSPs are colored orange
1 transmembrane helices). The MSP1D1 and MSP1E3D1 structures are drawn to the
Table 2
Phospholipids per leaﬂet, diameter and bilayer area of Nanodiscs [4,5].
MSP type Phospholipid
POPC DPPC DMPC Diameter (Å) Bilayer area (Å2)
MSP1D1 61 82 77 98 4400
MSP1E1D1 79 106 102 106 5700
MSP1E2D1 103 134 122 119 7200
MSP1E3D1 125 167 148 129 8900
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structed by adding additional 22-mer repeat units. Homogeneous
populations of the resulting Nanodiscs are routinely characterized
by SEC, analyzed for phospholipid content and structurally deﬁned
by solution X-ray scattering [4]. These biophysical efforts con-
ﬁrmed that Nanodisc diameter, MSP length, area per phospholipid
and number of phospholipids per Nanodisc are all interrelated, as
expected.
Another consequence of the MSP belt-length/Nanodisc diame-
ter relationship is that a high yield of homogeneous Nanodiscs re-
quires a deﬁned ratio of phospholipid to MSP during the assembly
process. If the lipid ratio during formation is too high, populations
of large particles are formed along with the Nanodiscs because a
higher area to perimeter is needed match the length of the hydro-
phobic MSP belt to the amount of phospholipid and total bilayer
surface area. The apolipoprotein literature contains many descrip-
tions of in vitro reconstituted high density lipoprotein (rHDL) par-
ticles containing integral numbers of apolipoprotein AI with two,
three and four associated with rHDL of increasing diameter and
phospholipid content [7,8]. MSP can also form lipid-poor particles
if the ratio of lipid to MSP is too low or unfavorable conditions are
used for disk formation. The phase diagram for assembling homo-
geneous Nanodisc preparations has been determined [1] and
molecular dynamics simulations demonstrated the deformation
of disks containing too few phospholipids because of the energetic
requirement of matching the length of the MSP belt to the length of
the bilayer hydrophobic edge [9,10]. Critical to obtaining homoge-
neous size assemblies is genetic engineering to delete from the
Apo-AI sequence the amino terminal residues that have low afﬁn-
ity for the discoidal bilayer state [4].
Thus, Nanodiscs are an ideal model membrane system with de-
ﬁned size and phospholipid composition. The membrane can be
composed of different mixtures of phospholipid types as well as
other components such as cholesterol among others (Table 1).
Hence the bilayer can be tailored in composition to suit a mem-
brane protein of interest and varied in composition to examine
functional effects of the bilayer environment. The Nanodisc bilayer
undergoes a phase transition similar to that of the pure phospho-
lipid component, though shifted by a few degrees to higher tem-
peratures and broadened due to the presence of the MSP [5,11]
and are quite similar to proteoliposomes. The Nanodisc-membrane
protein particle, due to its small size and robust nature, can be
treated much as a soluble protein target would be, such as sub-
jected to chromatography, rapid reaction methods, studied in solu-
tion phase at varying temperatures, frozen, lyophilized and
attached to matrices or surfaces through engineered MSP.
3. How are Nanodiscs formed?
Nanodiscs assemble from a mixture of detergent/phospholipid
micelles and MSP upon removal of the detergent. The phospholipid
(PL) to MSP molar stoichiometry is critical in this process and is
guided by considering the length of the MSP belt, which deter-
mines the energetic potential well for the optimal disc radius. If
the exact PL/MSP ratio is used, there is complete self-assemblywith a homogeneous size of Nanodiscs formed with little else in
solution. If the ratio is slightly off, the excess PL or scaffold protein
will appear as an aggregate in the void volume of a size exclusion
column. If the ratio is far from optimum, however, a wide variety of
lipoprotein particles are formed, certainly some Nanodiscs, but a
large quantity of aggregates of varying size. Hence if one is trying
a new lipid or lipid mixture it is imperative to determine the cor-
rect stoichiometry empirically. The importance of this parameter
leads to a quandary when membrane protein targets are included.
Here it is often not known how many lipids the target protein will
displace when assembled into the bilayer and hence the optimal
ratios of lipid to MSP are not known a priori. One experimental
solution is to reconstitute with a large excess of empty Nanodiscs
to minimize the ill-effects of the unknown contribution of target
protein to the membrane surface area. If, however, one is con-
strained to assembling at a high ratio of target to Nanodiscs, then
it is critical to carry out assembly at varying ratios of lipid with
success monitored by homogeneous SEC results.
The detergent used for initial solubilization is also critical. So-
dium cholate is ideal for the lipid fraction and is usually present
at a 2:1 mole ratio to total PL, or higher. Other detergents can work
equally well if the phospholipid goes fully into a clear solution of
micelles. Some researchers are hesitant to expose their membrane
protein to detergents like cholate, however the exposure time is
brief and negative effects are attenuated by the presence of the
phospholipid. Mixed detergents are another successful approach,
with cholate solubilizing the lipid and the secondary detergent (al-
kyl maltoside or glucoside, polyoxyethylene glycols, phoscholines,
CHAPS, etc.) dealing with the protein target (Table 1). In all cases,
the assembly process is initiated by removal of detergent by dial-
ysis (for dialyzable detergents) or treatment with porous polysty-
rene beads (Biobeads SM2 or Amberlite XAD2). It should be
noted that detergent removal by beads is both detergent and tem-
perature-dependent. For information on bead-based detergent re-
moval see [12,13]. Interestingly, we have shown that, contrary to
intuition, the loss of MSP, phospholipid or other components by
adsorption to the beads is minor. The temperature during assembly
is also important, with Nanodiscs forming most efﬁciently near the
phase transition temperature of the phospholipid. The reason for
this may be construed as an effect of the phase behavior and pos-
sibly the size and organization of the phospholipid/detergent mi-
celle at some point during, or perhaps throughout the process of
detergent removal. For example, rHDL is known to form from mix-
tures of phospholipid vesicles and Apo AI at the phase transition
temperature, presumably due to the presence of bilayer defects.
Nanodisc formation depends upon the initial state of the mixture
of phospholipid, cholate and MSP. Phospholipid in a mixed lamel-
lar–micellar phase at the start of detergent removal correlates with
poor Nanodisc formation and the presence of lipid-poor particles
[1]. There is also the feeling, though with little experimental data,
that the speed of detergent removal is also important. The desorp-
tion rate from target protein(s), lipid and scaffold are different and
dependent on the choice of detergent(s) used. Hence the ratio of
hydrophobic beads to protein/lipid is an additional parameter in
the assembly process.
The addition of cholate to preformed Nanodiscs may be inter-
preted as the reverse of the process of Nanodisc formation as deter-
gent is removed. The process of Nanodisc disassembly by addition
of cholate was also studied by a combination of molecular dynam-
ics simulation and SAXS [2]. Disassembly proceeds with cholate
insinuating itself between the MSP and the edge of the phospho-
lipid bilayer domain. Further additions of cholate result in a pertur-
bation of the MSP, which starts to ﬂuctuate in spatial structure. An
even further increase in the cholate to phospholipid ratio results in
the appearance of a more spherical particle shape with MSP still
associated. The experimental SAXS results agreed qualitatively
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dynamics simulations.
Although there have been several recent theoretical approaches
to understanding the Nanodisc assembly process [2,3,9,14] clearly
more effort is needed for a clear picture of the physics and kinetics.4. How are proteins assembled into Nanodiscs?
In the majority of cases utilized in our laboratory, the mem-
brane protein target of interest is completely pre-solubilized with
a compatible detergent and mixed with the Nanodisc assembly
components. Care is required in these steps since it is widely rec-
ognized that removal of a protein from the membrane can be most
difﬁcult: Even as the protein appears to be solubilized it can still be
aggregated or undergo time-dependent aggregation [15]. If deter-
gent solubilization is accomplished, however, it is very likely that
the protein will self-assemble with PL and MSP into Nanodiscs
when the detergent is removed. In a simple scenario one can think
of the membrane protein as a solute in the phospholipid/detergent
phase and Nanodisc formation proceeding as usual upon detergent
removal. As detergent is removed, the relevant recognition events
form target protein–lipid and lipid–lipid contacts as the Nanodisc
bilayer formed, with the target protein ultimately incorporated
into the bilayer in its native-like conﬁguration [9]. With more com-
plex protein targets, the situation is more complicated due to mul-
tiple competing pathways such as occurs when the protein tends
to self-aggregate [16]. The critical branch point is this non-produc-
tive self-aggregation and the formation of the correct protein–lipid
contacts. The presence of large self-aggregates can usually be de-
tected by size exclusion chromatography, although sometimes
these elute near that of correctly formed Nanodiscs. If aggregates
are suspected, a re-injection of a fraction of the peak can often
be used to verify this scenario. A simple means to overcome the
self-aggregation is to use a large excess of Nanodisc components
in the reconstitution, i.e. excess lipid and MSP.
A precise dynamical and structural picture of membrane pro-
tein self-assembly into Nanodiscs is in its infancy. One interesting
question is at what point in detergent removal is a membrane pro-
tein ‘‘trapped” within the forming Nanodisc structure? For exam-
ple, the rate of detergent removal and Nanodisc formation could
outpace the rate of productive membrane protein forming oligo-
mers. There are examples of liposome reconstitutions where the
speed of detergent removal and also type of detergent results in
an enrichment of protein compared to phospholipid in a fraction
of liposomes [16]. This outcome suggests a coexistence of different
phases and preferential partitioning of membrane protein during
removal of detergent. Experimental observations, as well as molec-
ular dynamics, of what is occurring during the assembly of proteins
into the Nanodisc and the properties of the mixed micelles of
membrane protein, lipid, detergent and MSP along the path to
Nanodisc formation would be very useful and an important inroad
to understanding chemical and biological self-assembly.5. Examples of proteins assembled into Nanodiscs
5.1. Cytochrome P450
A particularly powerful aspect of the Nanodisc system is that it
can be used to isolate protein in a known monomeric or oligomeric
state, a task difﬁcult or impossible in liposomes or detergents. CYP
3A4, a human hepatic drug metabolizing cytochrome P450, is an
example in which the state of the protein and thus function is af-
fected by aggregation [17]. CYP3A4 shows higher apparent cooper-
ativity of multiple testosterone binding and nearly full spin
conversion of the heme iron upon ligand binding in Nanodiscscompared to detergent-solubilized preparations, with such differ-
ences attributed to detergent-induced effects and/or aggregation.
In the absence of detergent, the aggregate displays multi-exponen-
tial kinetics of reduction by dithionite due to heterogeneity of the
enzyme [18]. In contrast, monomeric CYP3A4 in Nanodiscs dis-
plays clean monophasic reduction kinetics. CYP3A4 in liposomes
at high lipid stoichiometry also behaves as homogeneous mono-
mer. At lower lipid stoichiometry heterogeneous behavior arises
due to self-association of the CYP3A4, while Nanodiscs prohibit dy-
namic self-association as there is only one enzyme present within
the particle. Similarly, redox potential measurements using Nano-
discs provide a homogeneous monomeric form of the enzyme for
facile electrode interactions [19]. The Nanodisc thus represents a
clean way to monitor molecular function of CYP in a bilayer as a
monomeric species [20,21].
Assembly of multiple integral membrane proteins, starting with
puriﬁed targets, was demonstrated in the case of CYP3A4 and its
redox partner, cytochrome P450 reductase [21], as well as Arabid-
opsis CYP73A5, a cinnamate hydroxylase, with its P450 reductase
using heterologously expressed crude membrane fractions [22].
With heterologously expressed proteins, isolating a Nanodisc with
P450 and reductase is accomplished using differential afﬁnity tags,
in this case ADP-sepharose as afﬁnity ligand for the reductase and
metal chelate chromatography to bind the histidine tag on the
CYP3A4. Nanodiscs can also be assembled directly from crude
membrane preparations to afford the target protein and native lip-
ids in the resulting Nanodisc bilayer [23]. Structural investigations
of membrane proteins are also enabled by the Nanodisc technol-
ogy. For example, Magic-angle solid state NMR using 13C,15N-la-
beled proteins was used to gain structural insight of the
encircling MSP as well as incorporated human CYP3A4 [24].
5.2. Blood coagulation and human tissue factor
An interesting use of Nanodiscs to control the microenviron-
ment around a protein was realized in investigations of blood clot-
ting [25] where the activity is dependent on the phospholipid
composition. The complex of the integral membrane protein tissue
factor (TF) together with the soluble factor VIIa (FVIIa) initiates the
blood coagulation cascade. The recruitment of FVIIa requires acidic
phospholipid and calcium cation to react via the c-carboxyglutam-
ic acid (Gla) domains present in the factors. Acidic phospholipids
such as phosphatidylserine (PS) tend to undergo cluster formation
in large-scale bilayers due to multi-modal chelate interactions
with divalent cations or charge interaction with positively charged
proteins [26]. A Nanodisc is 600-fold smaller in bilayer surface area
compared to a typical 100 nm diameter liposome, thus prohibiting
the large-scale clustering of PS that occurs in liposomes and con-
trolling the localized number of PS molecules [27]. This example
also illustrates how the Nanodisc system can be used to provide
coupling to a surface for precise measurement of macromolecular
association. In this case the binding of factor X and factor VII were
measured by surface plasmon resonance [25].
5.3. Bacteriorhodopsin
The light driven proton pump bacteriorhodopsin (bR) is a
mainstay of membrane protein research. bR incorporates very
efﬁciently into Nanodiscs as a monomer (70–90%) and the Nano-
disc-bR monomer was used to address the structure and func-
tion of a multi-pass membrane protein Nanodisc assembly
[28]. The resulting size and shape of the nanoparticle assembly
was determined by size exclusion chromatography, atomic force
microscopy and transmission electron microscopy. The stoichi-
ometry and composition were measured spectroscopically and
chemically, revealing that the assembled Nanodisc complex
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(dimyristoylphosphatidylcholine [DMPC]). Native function of bR
was determined using spectroscopic identiﬁcation of the M410
photocycle intermediate and retinal binding. Determination of
phospholipid bilayer organization was inferred from measure-
ment of ﬂuorescent lipidic probe orientation in bR-Nanodiscs
oriented on a glass surface and from electron microscopy with
a resultant structural picture that is illustrated in Fig. 1.
Membrane protein oligomers are a focus of interest and again
bR proved to be a useful subject [29]. Bacteriorhodopsin forms 2-
D crystals composed of trimers in its native state. bR in its trimeric
form shows a positive and a negative peak in the circular dichroism
spectrum of the chromophore due to exciton splitting arising from
the geometry of the three chromophores thus providing an easy as-
say of oligomerization [30]. The reconstitution was optimized at
three bR per Nanodisc by varying the phospholipid ratio and
assessing the reconstitution by SEC. Four sizes of Nanodiscs were
tested. Analysis of the main Nanodisc-bR peak revealed that the
two smallest Nanodiscs did not exhibit the trimer circular dichro-
ism signature presumably due to insufﬁcient amounts of phospho-
lipid. In larger Nanodiscs, more trimer formed than one would
expect for bR incorporated with random topological orientation.
Therefore, oligomerization must occur before Nanodiscs are com-
pletely assembled.
5.4. G-protein coupled receptors
Insight into the functions of the large family of 7-TM receptors
has been aided by biochemical and biophysical studies of rhodop-
sin and the b2 adrenergic receptor. We have extensively used these
systems to prove the utility of Nanodiscs for the broad class of
GPCR drug targets. b2AR was one of the ﬁrst receptors assembled
into Nanodiscs [31], with efﬁcient assembly (54% of starting activ-
ity recovered) and resulting agonist and antagonist association
constants similar to literature values. b2AR-Nanodiscs also coupled
to its G-protein (Gs), however the amount of coupling based on
agonist binding to high-afﬁnity receptor was low. The groups of
Kobilka and Sunahara have subsequently used rHDL (formed using
apolipoprotein AI) to reconstitute b2AR and showed that full cou-
pling could be achieved only at very high concentrations of G-pro-
tein added to the b2AR rHDL [32]. The solubility and therefore
accessibility of G-protein is an issue when adding G-proteins
highly modiﬁed with hydrophobic lipids to preformed receptor-
Nanodiscs.
Rhodopsin is a light-activated GPCR present in photoreceptor
cells of the retina and has been proposed to form dimers and high-
er order oligomers based on AFM and EM studies [33,34]. We
reconstituted rhodopsin into our larger Nanodiscs with both one
and two rhodopsin molecules per Nanodisc and compared their
functionality [35]. The rhodopsin monomer Nanodiscs assemble
at high yield in the presence of a ﬁve-fold excess of Nanodiscs.
Two-rhodopsin Nanodiscs were formed at an assembly ratio of
two rhodopsins per Nanodisc. One- and two-rhodopsin Nanodiscs
could be separated and puriﬁed on sucrose density gradients. Both
species were found to activate transducin with high efﬁciency,
near the diffusional rate limit. The Nanodiscs containing two rho-
dopsins were half as efﬁcient as Nanodiscs containing one rhodop-
sin on a per-rhodopsin basis. Binding of transducin was measured
using an extra-metaII assay in which transducin binding converts
MI absorbing at 460 nm to MII absorbing at 380 nm [36]. The result
was that while the binding afﬁnities were about the same, only half
of the rhodopsin present in a two-rhodopsin Nanodisc could form
MII at saturating amounts of transducin. One hypothesis is that di-
mers form and that only one subunit in a dimer can interact with
transducin at a time due to steric reasons [35]. More recently,rHDL-rhodopsin monomers have also been used to address the
possible requirement for dimerization [37]. The common conclu-
sion of these investigations is that monomeric rhodopsin can efﬁ-
ciently conduct signal transduction.
5.5. Bacterial chemoreceptor
More complex assemblies of integral membrane proteins are
also possible to achieve in Nanodiscs. Tar is a bacterial chemore-
ceptor that can form trimers of dimers and extended arrays of tri-
mers of dimers. To understand function of single dimers versus
trimers of dimers, Tar was incorporated into Nanodiscs as a way
of controlling the stoichiometry of interaction [38]. By using excess
Nanodisc components, single dimers were found in Nanodiscs.
Upon decreasing the Nanodisc component in the assembly mix-
ture, multiple dimers were found per Nanodisc with the average
number dependent on the assembly ratio. Functional assays for li-
gand binding, CheR catalyzed methylation, phospho-CheB-cata-
lyzed deamination and kinase activity were performed on
samples containing varying numbers of dimers. Single dimers were
found to bind ligand, transmembrane signal, promote deamination
and methylation, indicating that trimers are not necessary for
these functions. However, kinase activation showed a peak value
at an average of three dimers per Nanodisc.
5.6. The peptide translocon complex
SecYEG is a protein translocon complex that requires oligomers
for function. The protomer, a heterotrimer having 15 transmem-
brane helices was put into Nanodiscs as single protomers for func-
tional studies [39,40]. A fundamental question was what functions
can be attributed to protomer and what functions can be attributed
to higher order oligomers. SecA, a soluble motor protein, was found
to bind the SecYEG protomer. Additionally phosphatidylglycerol
co-incorporated into the Nanodiscs was found to increase the afﬁn-
ity for SecA. Syd, a SecYEG interacting protein, was found to bind
the SecYEG protomer and to displace SecA. This study demon-
strates the use of Nanodiscs to control membrane protein associa-
tion state in a membrane of deﬁned composition to determine
functional aspects of the membrane protein-soluble partner
interactions.
5.7. Receptor tyrosine kinase
Epidermal growth factor receptor (EGFR) has been assembled
into Nanodiscs to confer stability of its kinase activity [41]. The
EGF-bound dimer in detergent was used as starting material for
Nanodisc assembly. Single EGFR dimers were placed into Nano-
discs and kinase activity was demonstrably stabilized in Nanodiscs,
as well as liposomes, with 80% activity remaining at 24 h compared
to 28% remaining activity in detergent.
6. Nanodiscs on surfaces
A powerful feature of Nanodiscs is the ability to attach the
membrane protein stabilized in Nanodiscs to surfaces via tags
on the membrane scaffold protein (MSP). Various afﬁnity tags
can be attached to the MSP. For instance, the MSP 6xHis tag
has been used to bind PS-containing Nanodiscs to a Ni-NTA bio-
sensor chip to measure binding of factor X and of arrestin using
SPR [25,42]. Further, SPR was used to measure binding of cholera
toxin to ganglioside-containing Nanodiscs which were immobi-
lized using similar methodology [43]. Nanodiscs containing rho-
dopsin were patterned via binding of the 6xHis tags on
Nanodiscs to a nickel charged triaza-terminated self-assembled
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sin with its G-protein, transducin, was observed using SAMDI-
TOF (self-assembled monolayers for matrix assisted laser desorp-
tion ionization) mass spectrometry [44]. The detection is label-
free and enables identiﬁcation of the G-protein speciﬁcity of a
receptor based on mass.
LSPR (localized surface plasmon resonance) is observed when
light interacts with metal nanoparticles. LSPR is highly dependent
on the refractive index of the surrounding media and upon analyte
binding the extinction maximum wavelength of the nanoparticle
shifts, providing a mechanism for chemical and biological sensing.
The localized nature of the plasmon makes it much more sensitive
to changes in the local environment compared to gold ﬁlms typi-
cally used for SPR. CYP3A4 in Nanodiscs was covalently coupled
using carbodiimide chemistry to silver nanoparticle surfaces gen-
erated using nanosphere lithography. Drug binding to CYP3A4-
Nanodisc on the nanoparticle surface was detected using LSPR
wavelength shift [45]. The device was also able to detect the mode
of interaction of drugs with the enzyme because of the strong cou-
pling between the molecular resonances of heme in cytochrome
P450 and the nanoparticles LSPR.
Nanodiscs also simply adsorb to glass or mica surfaces repro-
ducibly with the bilayer plane parallel to the surface [46]. Such
adsorption has been used to orient Nanodiscs and protein contain-
ing Nanodiscs for interrogation by atomic force microscopy [47–
50]. Functional lipidic groups may also be used such as biotinylated
lipid that will interact with streptavidin treated surfaces [42,51].
Nanodiscs containing biotinylated lipid have been patterned using
microﬂuidic channels and challenged with streptavidin-coated
quantum dots ﬂowed through the same channels (Goluch, 2008).
7. Membrane protein structures via Nanodiscs?
Structure determination of membrane proteins is a widely-
sought goal. Solid state magic angle spinning NMR of a membrane
protein in Nanodiscs is an example of the use of Nanodiscs in this
ﬁeld [24]. Lyukmanova et al. have used rHDL particles formed with
apolipoprotein AI to incorporate the membrane active peptide
antiamoebin-I and the potassium channel KcsA for solution NMR
to obtain topological information on antiamoebin-I and to demon-
strate the promising uses Nanodisc-like particles for high resolu-
tion solution NMR of membrane proteins [52,53]. High
throughput screening has also been enabled using solution NMR
[54]. The case for cryoEM of membrane proteins and 3-D particle
reconstructions using Nanodiscs has also seen recent success.
8. What new applications of Nanodiscs can be envisioned?
Relevant technological applications should take advantage of
the properties of the Nanodisc such as its small size compared to
liposomes, less light scattering, faster diffusion, stability in shear
ﬂow, access to both sides of the protein in solution, the ability to
add probes to the Nanodiscs and a means for surface attachment
Thus far the only device-type technologies reported using Nano-
discs are the SAMDI-TOF [44], LSPR sensors [45] and microﬂuidic
pattering [42] and recent results using single wall carbon nano-
tubes and cantilever detection modalities. Reports of apolipopro-
tein-based nanoparticles in cell-free expression of membrane
proteins might be an emerging use of Nanodisc-like particles
[55–57]. Bacteriorhodopsin co-expressed with apolipoprotein AI
in the presence of liposomes and retinal cofactor appears to form
active bR in nanoparticles. Preformed rHDL were also used with
similar results where the soluble fraction of several membrane
proteins put into the cell-free expression increased to various ex-
tents [56].Acknowledgements
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